CDK7-IN-13
CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1) [1].
Product Specifications
CAS Number
[2765676-20-6]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk7-in-13.html
Solubility
10 mM in DMSO
Smiles
CS(C)(=O)=NC1=CC=CC2=C1NC=C2C3=NC(N[C@H]4CCCNC4)=NC=C3C(F)(F)F
Molecular Formula
C20H23F3N6OS
Molecular Weight
452.50
References & Citations
[1]Guanpeng Qiu, et al. Pyrimidinyl derivatives, method for the production thereof and use thereof. Patent CN114249712A.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal CEACAM5/CD66e Antibody (CB30) [DyLight 350]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
